Research-grade GHK-Cu and cosmetic-grade copper tripeptide-1 share a chemical identity, but the purity specifications, impurity profiles, and analytical documentation differ substantially a distinction examined later in this guide
These investigations are still in early stages, but they highlight the broad potential of this medication in managing complex, chronic diseases
Results, tolerability, and safety considerations vary based on individual health factors, concurrent medications, and therapeutic goals
Some users find that the gradual onset of slowed motility with daily dosing is actually easier to manage than the abrupt changes from weekly injections
99.86% independently tested by Freedom Diagnostics via HPLC with UV Detection and Mass Spectrometry (LCMS/MS)
Do not use Estimated Exposure to guide dosing